Chronic Pain and Hyperbaric Oxygen Therapy

Hyperbaric Oxygen Therapy (HBOT) involves breathing 100% oxygen within a pressurised chamber, which enhances oxygen absorption into the bloodstream due to the increased pressure. Traditionally used for conditions like decompression sickness, HBOT is now gaining popularity for treating a variety of other conditions, including chronic pain.

Chronic Pain: A Complex Challenge

Chronic pain, unlike acute pain, tends to be maladaptive and interferes with daily activities, leading to emotional distress and a diminished quality of life. Conventional treatments, whether pharmacological, non-pharmacological, or interventional, often offer only temporary or moderate relief and may have side effects that impact patient adherence. This highlights the necessity for new therapies that are both effective and well-tolerated.

How HBOT Works for Chronic Pain

HBOT is emerging as a promising non-invasive option. Increasing levels of research show that HBOT can significantly reduce pain in various acute and chronic conditions, offering lasting relief with minimal side effects. Here’s how it works:

  1. Antinociceptive Effects:
    HBOT has been shown to block neural pathways that transmit pain signals in several animal studies, reducing the perception of pain.
  2. Release of Natural Opioids:
    HBOT promotes the release of the body’s natural opioids, which play a role in pain modulation, stress response, and immune function. These natural painkillers help in reducing pain without the side effects associated with synthetic opioids.
  3. Anti-Inflammatory Effects:
    HBOT suppresses the inflammatory response after injury, thereby decreasing the resulting inflammatory pain.. This anti-inflammatory effect is crucial for conditions where inflammation is a major pain contributor. Read more about Inflammation and Hyperbaric Oxygen Therapy.
  4. Neuropathic Pain (Nerve Pain):
    In studies involving rats with nerve injuries, HBOT improved blood flow, reduced swelling, and protected cells. It also reduced pain sensitivity in animals with various types of nerve injuries. A recent study found that HBOT reduced pain sensitivity, oxidative stress, and spinal cell activation.

HBOT in the Treatment of Human Pain

Although extensive evidence supports HBOT’s effectiveness in animal models, trials in human pain conditions have been limited. Nonetheless, preliminary findings indicate that HBOT may be beneficial for the following conditions, though further research is necessary:

  1. Migraine and Cluster Headaches:
    Numerous studies have demonstrated HBOT’s effectiveness in treating and preventing migraines and cluster headaches. While some studies were suboptimally designed, collectively they provide evidence that HBOT is effective in alleviating acute migraine attacks but not in preventing future episodes.
  2. Fibromyalgia:
    Fibromyalgia, a chronic pain condition with widespread discomfort and associated symptoms like fatigue and sleep issues, may involve muscle degeneration due to local oxygen deficiency. HBOT has been suggested to complement medications by increasing tissue oxygen levels, potentially improving muscle function and alleviating symptoms. A 2004 study revealed a significant reduction in the number of tender points and an increased pain threshold in patients receiving HBOT compared to those in the sham treatment group, with these benefits persisting after 15 sessions.
  3. Complex Regional Pain Syndrome (CRPS):
    A double-blind, randomised controlled trial (RCT) indicated that patients treated with HBOT experienced significantly reduced pain scores both after the 15th session and 45 days later.
  4. Trigeminal Neuralgia:
    A small clinical trial showed that people receiving HBOT used significantly less pain medication after 10 days of treatment, and the benefits lasted for 60 to 90 days afterwards.

Conclusion

Hyperbaric Oxygen Therapy is gaining recognition in the multidisciplinary management of chronic pain. By improving oxygen delivery, reducing inflammation, and promoting natural pain relief mechanisms, HBOT offers a promising non-invasive option for those suffering from chronic pain. As research continues to expand, HBOT may become a vital component in chronic pain management, providing lasting relief and improving the quality of life for many patients.

Click here to learn more about Hyperbaric Oxygen Therapy and book an appointment.

References

Bennett, M.H., French, C., Schnabel, A., Wasiak, J. & Kranke, P. 2008, “Normobaric and hyperbaric oxygen therapy for migraine and cluster headache”, Cochrane Database of Systematic Reviews, , no. 3.

Chung, E., Zelinski, L.M., Ohgami, Y., Shirachi, D.Y. & Quock, R.M. 2010, “Hyperbaric oxygen treatment induces a 2-phase antinociceptive response of unusually long duration in mice”, The journal of pain, vol. 11, no. 9, pp. 847-853.

George Mychaskiw, I., Pan, J., Shah, S., Zubkov, A.Y., Clower, B., Badr, A.E. & Zhang, J.H. 2005, “Effects of hyperbaric oxygen on skin blood flow and tissue morphology following sciatic nerve constriction”, Pain Physician, vol. 8, no. 2.

Gu, N., Niu, J., Liu, W., Sun, Y., Liu, S., Lv, Y., Dong, H., Song, X. & Xiong, L. 2012a, “Hyperbaric oxygen therapy attenuates neuropathic hyperalgesia in rats and idiopathic trigeminal neuralgia in patients”, European Journal of Pain, vol. 16, no. 8, pp. 1094-1105.

Gu, N., Niu, J., Liu, W., Sun, Y., Liu, S., Lv, Y., Dong, H., Song, X. & Xiong, L. 2012b, “Hyperbaric oxygen therapy attenuates neuropathic hyperalgesia in rats and idiopathic trigeminal neuralgia in patients”, European Journal of Pain, vol. 16, no. 8, pp. 1094-1105.

Heeman, J.H., Zhang, Y., Shirachi, D.Y. & Quock, R.M. 2013, “Involvement of spinal cord opioid mechanisms in the acute antinociceptive effect of hyperbaric oxygen in mice”, Brain research, vol. 1540, pp. 42-47.

Kiralp, M.Z., Yildiz, Ş, Vural, D., Keskin, I., Ay, H. & Dursun, H. 2004, “Effectiveness of hyperbaric oxygen therapy in the treatment of complex regional pain syndrome”, Journal of international medical research, vol. 32, no. 3, pp. 258-262.

Ortega, M.A., Fraile-Martinez, O., García-Montero, C., Callejón-Peláez, E., Sáez, M.A., Álvarez-Mon, M.A., García-Honduvilla, N., Monserrat, J., Álvarez-Mon, M. & Bujan, J. 2021, “A general overview on the hyperbaric oxygen therapy: applications, mechanisms and translational opportunities”, Medicina, vol. 57, no. 9, pp. 864.

Sabato, F.D., Giacovazzo, M., Cristalli, G., Rocco, M. & Fusco, B.M. 1996, “Effect of hyperbaric oxygen on the immunoreactivity to substance P in the nasal mucosa of cluster headache patients”, Headache: The Journal of Head and Face Pain, vol. 36, no. 4, pp. 221-223.

Sutherland, A.M., Clarke, H.A., Katz, J. & Katznelson, R. 2016, “Hyperbaric oxygen therapy: a new treatment for chronic pain?”, Pain Practice, vol. 16, no. 5, pp. 620-628.

Yildiz, Ş, Kiralp, M.Z., Akin, A., Keskin, I., Ay, H., Dursun, H. & Cimsit, M. 2004, “A new treatment modality for fibromyalgia syndrome: hyperbaric oxygen therapy”, Journal of international medical research, vol. 32, no. 3, pp. 263-267.

Zhao, B., Meng, L., Ding, Y. & Cao, Y. 2014, “Hyperbaric oxygen treatment produces an antinociceptive response phase and inhibits astrocyte activation and inflammatory response in a rat model of neuropathic pain”, Journal of Molecular Neuroscience, vol. 53, pp. 251-261.